Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tumor regression reported for StressGen's stress gene therapy

May 8, 1997

Novel antitumor gene therapy under development at Oxford BioMedica

May 8, 1997

Highly effective anthrapyrazole described by Boehringer Mannheim and U. of Vermont

May 8, 1997

Phase I/II prostate cancer studies under way for DUROS leuprolide

May 7, 1997

BioChem Pharma's BCH-4556 to enter U.S. phase I trial in cancer

May 7, 1997

Cell Genesys files IND for cancer gene therapy

May 7, 1997

Positive phase II results for Hycamtin in small cell lung cancer

May 7, 1997

New antitumor agents from Banyu

May 7, 1997

Chiron and DepoTech complete NDA for DepoCyt

May 6, 1997

Cyclic hexapeptide antitumor agents described by Taisho

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...